What is the clinical evidence from this study?

Study design: Case Report. Population: Hypertrophic obstructive cardiomyopathy (n=1). Intervention: Septal myectomy and bioprosthetic mitral valve replacement.

What question did this study set out to answer?

To evaluate a rare trileaflet mitral valve configuration in a patient with hypertrophic obstructive cardiomyopathy and its surgical implications.

July 5, 2026Perfusion

Septal myectomy and bioprosthetic valve replacement resolve severe MR in HOCM with a rare trileaflet valve.

View Full Paper

Ask AI

Bookmark

Population

1 68-year-old woman with hypertrophic obstructive cardiomyopathy, severe mitral regurgitation, and a rare…

Design

Case_report

Follow-up

10 days postoperatively

Key result

Septal myectomy and bioprosthetic mitral valve replacement successfully treated severe mitral regurgitation in a patient with hypertrophic obstructive cardiomyopathy and a rare trileaflet mitral valve.

Authors

UKUjjawal Kumar DSDaniel Rohairan Sitaranjan FTFouad Taghavi

Discussion

Member takes

Overview

Supports detailed valve assessment in HOCM with MR; leaves open validation in larger cohorts.

Key Points

To evaluate a rare trileaflet mitral valve configuration in a patient with hypertrophic obstructive cardiomyopathy and its surgical implications.
Case report of a 68-year-old woman with hypertrophic obstructive cardiomyopathy and trileaflet mitral valve variant.
Utilized cardiac magnetic resonance and echocardiography for multimodal imaging assessment.
Undertook septal myectomy and bioprosthetic mitral valve replacement after failed medical management.
Successful surgical intervention resulted in excellent valve function postoperatively.
Patient was discharged on postoperative day ten with stable cardiac function.
Identified trileaflet mitral valve configuration as a significant factor in severe mitral regurgitation.

Study Design

Type

Case Report (n=1)

Structured PICO

Population

A 68-year-old woman with hypertrophic obstructive cardiomyopathy and severe mitral regurgitation due to a rare trileaflet mitral valve.

Intervention

Septal myectomy and bioprosthetic mitral valve replacement

Outcome

Surgical success and postoperative recovery

This case highlights a rare trileaflet configuration of the mitral valve contributing to severe mitral regurgitation in hypertrophic obstructive cardiomyopathy, underscoring the importance of detailed anatomical assessment in guiding surgical decision-making.

Cite This Study

Kumar et al. (2026) conducted a case report in Hypertrophic obstructive cardiomyopathy (n=1). Septal myectomy and bioprosthetic mitral valve replacement was evaluated. Septal myectomy and bioprosthetic mitral valve replacement successfully treated severe mitral regurgitation in a patient with hypertrophic obstructive cardiomyopathy and a rare trileaflet mitral valve.

synapsesocial.com/papers/6a49f70df5d1d45b288012b9 https://doi.org/10.1177/02676591261467978

View Full Paper

Ask AI

Bookmark

July 5, 2026Perfusion

Septal myectomy and bioprosthetic valve replacement resolve severe MR in HOCM with a rare trileaflet valve.

View Full Paper

Ask AI

Bookmark

Population

1 68-year-old woman with hypertrophic obstructive cardiomyopathy, severe mitral regurgitation, and a rare…

Design

Case_report

Follow-up

10 days postoperatively

Key result

Authors

UKUjjawal Kumar DSDaniel Rohairan Sitaranjan FTFouad Taghavi

Discussion

Member takes

Overview

Supports detailed valve assessment in HOCM with MR; leaves open validation in larger cohorts.

Key Points

To evaluate a rare trileaflet mitral valve configuration in a patient with hypertrophic obstructive cardiomyopathy and its surgical implications.
Case report of a 68-year-old woman with hypertrophic obstructive cardiomyopathy and trileaflet mitral valve variant.
Utilized cardiac magnetic resonance and echocardiography for multimodal imaging assessment.
Undertook septal myectomy and bioprosthetic mitral valve replacement after failed medical management.
Successful surgical intervention resulted in excellent valve function postoperatively.
Patient was discharged on postoperative day ten with stable cardiac function.
Identified trileaflet mitral valve configuration as a significant factor in severe mitral regurgitation.

Study Design

Type

Case Report (n=1)

Structured PICO

Population

A 68-year-old woman with hypertrophic obstructive cardiomyopathy and severe mitral regurgitation due to a rare trileaflet mitral valve.

Intervention

Septal myectomy and bioprosthetic mitral valve replacement

Outcome

Surgical success and postoperative recovery

Cite This Study

synapsesocial.com/papers/6a49f70df5d1d45b288012b9 https://doi.org/10.1177/02676591261467978

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark